In this Issue
Investigators provide overviews of current clinical trials evaluating a variety of techniques for treating superficial femoral artery disease.
By John R. Laird Jr, MD
VARICOSE VEIN INTERVENTIONS
With more studies on the horizon, foam therapy is finding its role in treating venous medical conditions.
By Jose I. Almeida, MD, FACS, RVT
Clinical aspects of ablating the incompetent anterior accessory great saphenous vein.
By James Laredo, MD, PHD; Byung B. Lee, MD, PHD; AND Richard F. Neville, MD
Dierk Scheinert, MD, discusses the THUNDER and FemPac trial results and previews new studies that will evaluate drug-coated balloons versus plain old balloon angioplasty.
A look at the ongoing trials of self-expanding stents in the superficial femoral artery.
By Khung Keong Yeo, MD, and John R. Laird Jr, MD
Principal investigators discuss the clinical study design and initial results with the Zilver PTX drug-eluting peripheral stent in the SFA.
By Michael D. Dake, MD; Gary M. Ansel, MD, FACC; and Anthony O. Ragheb, PHD
A new standard in femoropopliteal artery nitinol stent trial design.
By Krishna Rocha-Singh, MD, FACC, FSCAI, FSVM
How will cryotherapy compare to conventional balloon angioplasty in peripheral vascular interventions?
By Sivavasavi Dinakaran, MD; Praveen Mehta, MD; Daniel Tran, MSC; Emmanouil S. Brilakis, MD; Subhash Banerjee, MD; and Tony S. Das, MD
Nitinol self-expandable stent placement for the treatment of obstructive SFA disease.
By Andrew J. Feiring, MD, FACC, FSCAI
Comparing bare-nitinol stents to stent grafts in long superficial femoral artery lesions in this unique trial.
By Gary M. Ansel, MD, FACC; Patrick J. Geraghty, MD, FACS; Mark Mewissen, MD; and Michael R. Jaff, DO
With heparin bonded to the surface and a contoured edge, how will stent grafts perform in SFA revascularization?
By Richard R. Saxon, MD, FSIR
Shortly after the release of preliminary data in New Zealand and Germany, evaluation of the FlexStent system in the United States will begin later this year.
By William A. Gray, MD
The principal investigator of the COMPLIANCE 360º trial discusses its rationale, study design, and potential therapeutic implications.
By Raymond Dattilo, MD, FACC
An overview of the trials studying bare-metal stents in the superficial femoral and popliteal artery.
By Thomas Zeller, MD
CODING & REIMBURSEMENT
A look at the changes in the Physician Fee Schedule that will affect your practice in 2010.
By Katharine L. Krol, MD
Michael R. Jaff, DO, discusses the PAD Task Force’s recent initiative to increase awareness of peripheral artery disease.
A preview of today’s new products
Dr. Collins shares perspectives on the progress of medical care in New Orleans after Hurricane Katrina, the focus of this year’s All That Jazz meeting, and the evolution of modern stroke therapy.